GENVEC INC
8-A12G, 1998-06-12
PHARMACEUTICAL PREPARATIONS
Previous: NEW PARADIGM SOFTWARE CORP, 8-K/A, 1998-06-12
Next: ACACIA RESEARCH CORP, 4, 1998-06-12



<PAGE>
 
                                   FORM 8-A

                      SECURITIES AND EXCHANGE COMMISSION

                            WASHINGTON, D.C.  20549

               FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
                    PURSUANT TO SECTION 12(b) OR (g) OF THE
                        SECURITIES EXCHANGE ACT OF 1934


                                 GenVec, Inc.
- --------------------------------------------------------------------------------
            (Exact name of Registrant as specified in its charter)

              Delaware                                 23-2705690
- --------------------------------------------------------------------------------
(State of incorporation or organization)    (I.R.S. Employer Identification No.)


  12111 Parklawn Drive, Rockville, MD                     20852
- --------------------------------------------------------------------------------
(Address of principal executive offices)                (Zip Code)


Securities to be registered pursuant to Section 12(b) of the Act:

                                     NONE
- --------------------------------------------------------------------------------

Securities to be registered pursuant to Section 12(g) of the Act:

                   COMMON STOCK, PAR VALUE $0.001 PER SHARE
- --------------------------------------------------------------------------------
                               (Title of Class)
<PAGE>
 
Item 1.   Description of Registrant's Securities to be Registered
          -------------------------------------------------------

          Incorporated by reference to Description of Capital Stock section on
          pages 59-61 of Amendment No. 3 to the Registrant's Registration
          Statement on Form S-1 filed with the Securities and Exchange
          Commission on June 5, 1998 (file number 333-51475) (the "S-1
          Registration Statement").

Item 2.   Exhibits
          --------

          The following exhibits are filed as a part of this registration
          statement:

          1./1/     Specimen certificate for Registrant's Common Stock.

          2./2/     Certificate of Incorporation, as currently in effect.

          3./3/     Form of Amended and Restated Certificate of Incorporation to
                    be filed after the closing of the offering.

          4./4/     Bylaws of the Registrant, as currently in effect.

          5./5/     Bylaws of the Registrant, effective upon the closing of the
                    offering.

          6./6/     Registration Rights Agreement dated April 22, 1998 between
                    the Registrant and certain holders of the Registrant's
                    securities.
                    
____________        
/1/  Incorporated by reference to Exhibit 4.1 to the S-1 Registration Statement.
/2/  Incorporated by reference to Exhibit 3.2 to the S-1 Registration Statement.
/3/  Incorporated by reference to Exhibit 3.3 to the S-1 Registration Statement.
/4/  Incorporated by reference to Exhibit 3.4 to the S-1 Registration Statement.
/5/  Incorporated by reference to Exhibit 3.5 to the S-1 Registration Statement.
/6/  Incorporated by reference to Exhibit 10.20 to the S-1 Registration
     Statement.


                                      -2-
<PAGE>
 
                                   SIGNATURE

     Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the Registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereto duly authorized.

Date: June 12, 1998                 GENVEC, INC.



                                    By: /s/ Paul H. Fischer
                                       -------------------------------------
                                        Paul H. Fischer
                                        Chief Executive Officer


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission